Search

Compare products
Sort By:
Human F-box/LRR-repeat protein 17 (FBXL17) ELISA Kit
abx524480
Quantitative
Range: 0.156 ng/ml - 10 ng/ml
US$797.50 (96 tests)
Buy it NOW
Mouse F-box/LRR-repeat protein 17 (FBXL17) ELISA Kit
abx524481
Quantitative
Range: 0.156 ng/ml - 10 ng/ml
US$797.50 (96 tests)
Buy it NOW
F-Box/LRR-Repeat Protein 17 (FBXL17) Antibody
abx310885
Rabbit Polyclonal IgG
Tested Applications: ELISA, IHC
Reactivity: Human
US$188.50 (20 µg)
Buy it NOW
F-Box/LRR-Repeat Protein 17 (FBXL17) Antibody (HRP)
abx310886
Rabbit Polyclonal IgG
Tested Applications: ELISA
Reactivity: Human
US$188.50 (20 µg)
Buy it NOW
F-Box/LRR-Repeat Protein 17 (FBXL17) Antibody (FITC)
abx310887
Rabbit Polyclonal IgG
Reactivity: Human
US$188.50 (20 µg)
Buy it NOW
F-Box/LRR-Repeat Protein 17 (FBXL17) Antibody (Biotin)
abx310888
Rabbit Polyclonal IgG
Tested Applications: ELISA
Reactivity: Human
US$188.50 (20 µg)
Buy it NOW
Mouse FBXL17 siRNA
abx916560
Specificity: FBXL17 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Purity: > 97%
Form: Lyophilized
US$522.00 (15 nmol)
Buy it NOW
Human FBXL17 siRNA
abx916561
Specificity: FBXL17 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Purity: > 97%
Form: Lyophilized
US$522.00 (15 nmol)
Buy it NOW
Mouse FBXL17 shRNA Plasmid
abx974102
Specificity: FBXL17 shRNA Plasmid (Mouse) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA.
Form: Lyophilized
US$783.00 (150 µg)
Buy it NOW
Human FBXL17 shRNA Plasmid
abx962109
Specificity: FBXL17 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA.
Form: Lyophilized
US$783.00 (150 µg)
Buy it NOW